Answers are grounded in this paper and cite their sources.
Cross-sectional study evaluates inflammatory cytokines and their correlation with proteinuria in glomerulonephritis and nephrotic syndrome.
The aim of this cross-sectional study was to comparatively assess the levels of key pro-inflammatory (interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-α)) and fibrotic (transforming growth factor-beta1 (TGF-β₁)) cytokines in both serum and urine of patients with primary glomerulonephritis (GN) associated with nephrotic syndrome (NS), and to evaluate their associations with clinical indicators of disease activity—particularly daily proteinuria—as well as histological features of chronic kidney injury. A total of 85 adult patients with newly diagnosed GN and NS who were hospitalized at the Ivano-Frankivsk Regional Clinical Hospital between 2022 and 2024 were enrolled in the study, along with 20 demographically matched healthy volunteers serving as controls. All patients underwent comprehensive clinical, laboratory, and histopathological evaluation. The concentrations of IL-6, TNF-α, and TGF-β₁ were measured in both serum and urine samples using standardized sandwich enzyme-linked immunosorbent assay (ELISA) kits. Statistical analysis included comparisons between study and control groups, as well as correlation assessments between biomarker levels and clinical-histological parameters, such as daily protein loss and the chronicity index of renal biopsies. Patients with GN and NS showed significantly elevated levels of IL-6, TNF-α, and TGF-β₁ in both serum and urine compared to healthy controls (p<0.05), indicating activation of both systemic and localized inflammatory and fibrotic responses. Importantly, urinary IL-6 and TNF-α levels demonstrated moderate positive correlations with daily proteinuria (r=0.472 and r=0.546, respectively; p<0.05), while their serum levels did not show significant associations. Urinary TGF-β₁ exhibited a weak but statistically significant correlation with proteinuria (r=0.256; p<0.05) and a strong correlation with the histological chronicity score of kidney tissue damage (r=0.783; p<0.01), which incorporates parameters such as interstitial fibrosis, tubular atrophy, and global glomerulosclerosis. These findings highlight the diagnostic and prognostic utility of urinary cytokines as non-invasive biomarkers. Urinary IL-6 and TNF-α may be particularly useful for assessing local inflammatory activity and glomerular barrier dysfunction, while urinary TGF-β₁ appears to reflect longer-term fibrotic remodeling of renal parenchyma. The superiority of urinary biomarkers over their serum counterparts underscores their potential for integration into clinical protocols for disease monitoring in GN and NS. This study adds to the growing body of evidence supporting urinary cytokines as meaningful indicators of disease activity and chronic progression in glomerular diseases. Nevertheless, limitations such as the cross-sectional design, relatively small sample sizes in histological subgroups, and lack of follow-up data must be acknowledged. Future prospective, multicenter investigations with longitudinal follow-up are needed to validate these findings and further explore the role of urinary cytokines in predicting disease trajectory and response to therapy in patients with GN and nephrotic syndrome.
No takes yet. Share an insight, caveat, or question.
Mykhaloiko et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: